Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human trabecular meshwork organ culture.

Y Urakawa1, M Miyazaki, A Ishihara

  • 1Department of Ophthalmology, Shinshu University School of Medicine, Matsumoto, Japan.

Japanese Journal of Ophthalmology
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Observation of In-Ice Askaryan Radiation from High-Energy Cosmic Rays.

Physical review letters·2026
Same author

Evidence for a Spectral Break or Curvature in the Spectrum of Astrophysical Neutrinos from 5 TeV to 10 PeV.

Physical review letters·2026
Same author

Search for Extremely-High-Energy Neutrinos and First Constraints on the Ultrahigh-Energy Cosmic-Ray Proton Fraction with IceCube.

Physical review letters·2025
Same author

Measurement of Atmospheric Neutrino Oscillation Parameters Using Convolutional Neural Networks with 9.3 Years of Data in IceCube DeepCore.

Physical review letters·2025
Same author

Search for an eV-Scale Sterile Neutrino Using Improved High-Energy ν_{μ} Event Reconstruction in IceCube.

Physical review letters·2024
Same author

Observation of Seven Astrophysical Tau Neutrino Candidates with IceCube.

Physical review letters·2024

This study developed a 12-week organ culture system for human trabecular meshwork explants. Larger specimens maintained cellular integrity, proving useful for testing glaucoma treatments.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Tissue Engineering

Background:

  • The human trabecular meshwork (HTM) is crucial for aqueous humor outflow and intraocular pressure regulation.
  • Maintaining HTM in a viable ex vivo state is essential for studying ocular physiology and disease.
  • Current methods for HTM culture present limitations in long-term viability and cellular function.

Purpose of the Study:

  • To establish and validate a robust organ culture system for human trabecular meshwork.
  • To assess the long-term viability and cellular morphology of HTM explants in vitro.
  • To determine the suitability of the developed culture system for drug screening and mechanistic studies.

Main Methods:

  • Postmortem human trabecular meshwork explants were dissected into three specimen sizes (Types 1, 2, and 3).

Related Experiment Videos

  • Explants were cultured in a specialized medium supplemented with fetal bovine serum and chick embryo extract.
  • Specimens were maintained under controlled conditions (37°C, 5% CO2) for up to 12 weeks.
  • Morphological and morphometric analyses (light and electron microscopy) were performed to evaluate cell viability and structure.

    • Main Results:

    • Specimens of larger sizes (Types 1 and 2) exhibited normal morphology and cellular structure throughout the 12-week culture period.
    • Smaller specimens (Type 3) showed rapid cellular activation and significant cell loss post-explantation.
    • Light microscopy confirmed good preservation of trabecular cells in Types 1 and 2 specimens over 12 weeks.
    • Electron microscopy validated the structural integrity of larger HTM explants in culture.

    Conclusions:

    • A 12-week organ culture system for human trabecular meshwork has been successfully developed and validated.
    • Larger HTM explants (Types 1 and 2) demonstrate superior long-term viability and structural preservation.
    • This culture model is a promising tool for investigating the effects of various agents, including anti-glaucoma drugs, on the human trabecular meshwork.